Your session is about to expire
← Back to Search
Device
non-invasive transcranial electrical stimulation for Multiple Sclerosis
N/A
Waitlist Available
Led By Riley Bove, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-stim) and post-stimulation, up to 2 hours
Awards & highlights
Study Summary
This trial is investigating whether electrical stimulation can improve cognition in people with MS.
Eligible Conditions
- Multiple Sclerosis
- Cognitive Impairment
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre-stim) and post-stimulation, up to 2 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-stim) and post-stimulation, up to 2 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
EVO Performance Change From Baseline Assessment
Processing Speed Change From Baseline Assessment
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Stim2 low doseExperimental Treatment1 Intervention
This group will receive low dose non-invasive transcranial electrical stimulation
Group II: Stim1 high doseExperimental Treatment1 Intervention
This group will receive high dose non-invasive transcranial electrical stimulation
Group III: Sham controlPlacebo Group1 Intervention
This group will receive sham control non-invasive transcranial electrical stimulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
non-invasive transcranial electrical stimulation
2020
N/A
~60
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,495 Total Patients Enrolled
23 Trials studying Multiple Sclerosis
2,470 Patients Enrolled for Multiple Sclerosis
Riley Bove, MDPrincipal InvestigatorUniversity of California, San Francisco
6 Previous Clinical Trials
434 Total Patients Enrolled
6 Trials studying Multiple Sclerosis
434 Patients Enrolled for Multiple Sclerosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
UCSF Sandler Neurosciences Center
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger